Scott Ferguson Sachem Head Capital Management
Scott Ferguson is the founder of Sachem Head Capital Management, an activist and fundamental equity firm. He previously worked at firms including Corvex and built a reputation for research-driven campaigns at public companies. Ferguson’s filings and activist situations are followed closely in event-driven and engagement-oriented investing circles.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDK
CDK Global, Inc.
CDK
|
+$448M |
| 2 |
AGN
Allergan plc
AGN
|
+$106M |
| 3 |
Viatris
VTRS
|
+$11.8M |
| 4 |
Air Products & Chemicals
APD
|
+$8M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$90.8M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$80.8M |
| 3 |
Comcast
CMCSA
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.72% |
| 2 | Industrials | 38.35% |
| 3 | Materials | 9.33% |
| 4 | Consumer Staples | 6.97% |
| 5 | Communication Services | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CDK
1
DELISTED
CDK Global, Inc.
CDK
| $516M | 38.35% |
+12,647,333
| New | +$448M |
2014 Q4
0 quarters
|
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $206M | 15.32% |
800,000
+425,000
| +113% | +$106M |
2014 Q3
1 quarter
|
|
3
Zoetis
ZTS
$34.1B
| $189M | 14.07% |
4,395,000
| – | – |
2014 Q1
3 quarters
|
|
|
4
Viatris
VTRS
$23.9B
| $139M | 10.34% |
2,465,000
+220,000
| +10% | +$11.8M |
2014 Q1
3 quarters
|
|
|
5
Air Products & Chemicals
APD
$70.5B
| $125M | 9.33% |
940,470
+63,238
| +7% | +$8M |
2014 Q1
3 quarters
|
|
6
Dollar General
DG
$29.6B
| $93.7M | 6.97% |
1,325,000
| – | – |
2014 Q3
1 quarter
|
|
|
TFCFA
7
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $75.7M | 5.63% |
1,971,762
+45,262
| +2% | +$1.6M |
2014 Q1
3 quarters
|
|
|
8
Comcast
CMCSA
$89.3B
| – | – |
-1,640,000
| Closed | -$44.1M | – |
|
|
TWC
9
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| – | – |
-563,300
| Closed | -$80.8M | – |
|
|
AGN
10
DELISTED
Allergan Inc
AGN
| – | – |
-509,800
| Closed | -$90.8M | – |
|
Similar funds
Scott Ferguson's Q4 2014 Portfolio in Review
As of Q4 2014, Scott Ferguson held 11 positions worth $1.34B, up 50% from $897M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Scott Ferguson deployed $287M of net new capital in Q4 2014, opening 1 new position and adding to 4 existing holdings. Its largest new stake was CDK Global, Inc.: 12,647,333 shares worth $516M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 50% a quarter earlier, followed by Industrials and Materials.
On the sell side, the most notable exit was Allergan Inc, an estimated $90.8M sold.
- Scott Ferguson's largest Q4 2014 buy was CDK Global, Inc.: 12,647,333 shares worth $516M.
- Scott Ferguson added most to Allergan plc in Q4 2014, an estimated $106M increase.
- Scott Ferguson fully exited Allergan Inc in Q4 2014, selling an estimated $90.8M.
- Scott Ferguson's ten largest holdings make up 100% of its $1.34B portfolio in Q4 2014.
- Scott Ferguson opened 1 new position and closed 4 in Q4 2014.
- Scott Ferguson's portfolio value rose 50% quarter-over-quarter to $1.34B.
Based on Sachem Head Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.